NEURODEGENERATIVE DISEASE IN 2015: Targeting tauopathies for therapeutic translation

    loading  Checking for direct PDF access through Ovid

Abstract

Tau protein abnormalities are key pathogenic features of Alzheimer disease and other neurodegenerative diseases. In 2015, new studies of the less common tauopathies, including progressive supranuclear palsy, chronic traumatic encephalopathy and frontotemporal lobar degeneration, have identified in vivo biomarkers and mechanisms that initiate tau pathology.

Related Topics

    loading  Loading Related Articles